New prognostic biomarkers and therapeutic effect of bevacizumab for patients with non-small-cell lung cancer
Maiko Niki, Takashi Yokoi, Takayasu Kurata, Shosaku Nomura First Department of Internal Medicine, Kansai Medical University, Hirakata, Osaka, Japan Background: Several biomarkers have emerged as potential prognostic and predictive markers for non-small-cell lung cancer (NS...
Main Authors: | Niki M, Yokoi T, Kurata T, Nomura S |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-08-01
|
Series: | Lung Cancer : Targets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/new-prognostic-biomarkers-and-therapeutic-effect-of-bevacizumab-for-pa-peer-reviewed-article-LCTT |
Similar Items
-
Predicting disease progression in advanced non-small cell lung cancer with circulating neutrophil-derived and platelet-derived microparticles
by: Tingting Liu, et al.
Published: (2021-08-01) -
Intracameral bevacizumab administered for non-small cell lung cancer metastasis to iris
by: Jonathan C. Schell, et al.
Published: (2011-05-01) -
Association between an elevated level of HMGB1 and non-small-cell lung cancer: a meta-analysis and literature review
by: Xia QS, et al.
Published: (2016-06-01) -
Application of Bevacizumab in Non-small Cell Lung Cancer
by: Ping XU, et al.
Published: (2017-04-01) -
Bevacizumab-Containing Chemoimmunotherapy for Recurrent Non-Small-Cell Lung Cancer after Chemoradiotherapy: Case Report
by: Nobutaka Kataoka, et al.
Published: (2021-05-01)